TGen News & Press Releases : TGen receives $50,000 to find genetic origins of rare breast cancer

3-mile fun run-walk around Tempe Town Lake will raise funds for TGen

TEMPE, Ariz. - March 26, 2010 - Strides for Life-Arizona is a family-friendly fun run-walk that will take place on April 11 around part of Tempe Town Lake in an effort to raise funds for lung cancer research at the Translational Genomics Research Institute (TGen).

This will be the first Strides for Life event in Arizona and the first outside of New York, where the event's organizer, the Lung Cancer Research Foundation (LCRF), has raised more than $1.7 million for lung cancer research since 2006, when it organized its first run-walk in Southampton, N.Y.

LCRF, a leader in helping advance the pace of lung cancer research, previously awarded $75,000 to TGen to name the Lung Cancer Research Foundation Bench, which enables TGen scientists to conduct groundbreaking investigations.

"Given the world-class research resources in the state, Arizona was the first choice in expanding the Foundation's signature event, especially since a portion of funds raised will go towards TGen's lung cancer research program," said Laurie Carson, founder of the LCRF.

"Funding for lung cancer research and education is crucial, yet even though the disease is responsible for almost one-third of all cancer deaths in the nation, there is a severe scarcity of funds,'' Carson said.

Lung cancer is the leading cause of cancer death worldwide, annually killing 1.3 million people. Nearly 220,000 new cases of lung cancer will be diagnosed this year in the U.S., where more than 159,000 men and women will die from the disease, according to estimates by the National Cancer Institute.

There remains no practical way to screen for lung cancer. As a result, nearly 75 percent of patients are diagnosed with advanced-stage disease, leaving few options for treatment. TGen's Lung Cancer Research Lab is at the forefront of efforts to improve lung cancer detection, develop new therapies and enhance our understanding of tumor biology.

Among American women, lung cancer is responsible for more cancer deaths than breast cancer and all gynecological cancers combined. And while the link between smoking and lung cancer is well established, nearly 50 percent of new lung cancer cases are former smokers and about 15 percent have never smoked.

Registration for Strides for Life-Arizona will start at 7:30 a.m. on April 11 at Tempe Arts Park, 700 W. Rio Salado Parkway, on the south side of Tempe Town Lake, midway between Priest Drive and Mill Avenue, near the Tempe Center for the Arts.

Races will begin at 9 a.m. The first 500 participants in the run-walk will receive Strides for Life t-shirts. The 50-yard dash for children ages 2-10 will start at 10:15 a.m., with the first 200 participants receiving a Strides for Life medals and t-shirts. Awards will be given to the first adult, youth and first five members of a team to cross the finish line.

The run-walk for adults is $25 ($30 after April 4), and $10 for youths under 18. There are no fees for children in the 50-yard dash. More information, please contact the TGen Foundation at www.tgenfoundation.org or 602-343-8470; or the LCRF at www.lungfund.org or 800-380-7988.

*

About The Lung Cancer Research Foundation
The Lung Cancer Research Foundation is a 501(c)(3) non-profit organization that supports national research and activities to develop better treatments, screening and prevention of lung cancer. It was founded in 2005 by Laurie Carson, who lost two family members to lung cancer: a brother who never smoked, and an uncle who had quit smoking 20 years before his death. The Foundation's signature fundraising event, Strides for Life, has raised more than $1.7 million since 2006 to fund scientific research grants at leading cancer centers across the country. For more information, visit www.lungfund.org.

*

About The Translational Genomics Research Institute
The Translational Genomics Research Institute (TGen) is a Phoenix, Arizona-based non-profit organization dedicated to conducting groundbreaking research with life-changing results. Research at TGen is focused on helping patients with diseases such as cancer, neurological disorders and diabetes. TGen is on the cutting edge of translational research where investigators are able to unravel the genetic components of common and complex diseases. Working with collaborators in the scientific and medical communities, TGen believes it can make a substantial contribution to the efficiency and effectiveness of the translational process. TGen is affiliated with the Van Andel Research Institute in Grand Rapids, Michigan. For more information, visit www.tgen.org.

# # #


Search



Media Contact



RSS Feed

Newsletter